Last reviewed · How we verify
NCT06316362
Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine
Phase 2 trial testing SMOF lipid 20% in Acute Poisoning in 40 participants. Completed in 28 February 2023.
1 February 2023
Quick facts
| Lead sponsor | Alexandria University |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2022 |
| Primary completion | 1 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- SMOF lipid 20% — full drug profile →
- Standard treatment for carbamazepine toxicity
Conditions studied
- Acute Poisoning — all drugs for Acute Poisoning →
Sponsor
Alexandria University
Who can join
Adults 18 to 54, any sex, with Acute Poisoning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the current study was to evaluate whether SMOF lipid administration could be used as an adjuvant therapy to treat acute, moderate-to-severe carbamazepine poisoning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06316362
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SMOF lipid 20%
Trials testing the same drug.
- NCT06413589 — Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine · Phase 2 · completed
Other recruiting trials for Acute Poisoning
Currently open trials in the same condition.
- NCT06447584 — Clinical Spectrum and Outcome of Poisoning in Children Admitted to the Pediatric Emergency and Intensive Care Units at S · recruiting
Other Alexandria University trials
Trials by the same sponsor.
- NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
- NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
- NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
- NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06316362 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alexandria University
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06316362.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing